1. Cisplatin/gemcitabine/nivolumab
   , 2023, Reactions Weekly CrossRef
2. Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy
   Trie Arni Djunadi et al, 2024, Clinical Lung Cancer CrossRef
3. IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
   Yutao Liu et al, 2023, Clinical and Translational Medicine CrossRef